Challenges in lung transplantation in Japan  by Chida, Masayuki
Contents lists available at ScienceDirectRespiratory Investigation
r e s p i r a t o r y i n v e s t i g a t i o n 5 3 ( 2 0 1 5 ) 4 9 – 5 0journal homepage: www.elsevier.com/locate/resinvEditorialChallenges in lung transplantation in JapanIn Japan, lung transplantation cases have increased since
the ﬁrst living-donor transplantation was performed in 1998
and ﬁrst brain-dead-donor transplantation in 2000. In 2014,
41 brain-dead and 20 living-donor lung transplantations were
performed. By contrast, according to the Registry Report of
the International Society for Heart and Lung Transplantation
(ISHLT), over 3000 lung transplantations are performed
annually worldwide [1]. Thus, although the number of trans-
plantations is increasing in Japan, there are relatively few
cases because of a severe donor shortage.
In 2013, registered donors numbered 126, and the mean
waiting period for potential recipients was 2–3 years. Accord-
ingly, the rate of mortality while awaiting transplantation is
high at 40%. To cope with this situation, a Japanese equiva-
lent of the lung allocation score system is being developed.
Because mortality rates while awaiting transplantation vary
by disease, the bronchiectasis and interstitial pneumonia
scores are compensated for by adding 6–12 months due to
the delay. At present, the conditions of registrants are ill
deﬁned and need to be clearly presented in order to study the
survival beneﬁt of transplantation by disease classiﬁcation.
Another measure being undertaken is the use of marginal
donors. Compared to the United States, the rate of marginal
donor use is higher in Japan due to the shortage of donors. In
Western countries, the rate of brain-dead lung usage is
approximately 30%, while the rate in Japan is 60%, and
marginal donors who deviate from more than 1 of 10 items
in the ISHLT standard adaptive criteria comprise 88% of
cases. However, the mortality rate is 63% when marginal
donors who deviate from the criteria by greater than four
items are used. Accordingly, the evaluation of marginal donor
status is important.
In Japan, the medical consultant (MC) system plays an
important role in the utilization of marginal donors [2]. Using
this system, an MC is dispatched from the regional institution
for transplantation anytime a brain-dead donor candidate
emerges; the MC then advises the donor's primary physician
in maintaining the lung in a favorable condition until the
lung extraction team arrives. Although a considerable burden
is imposed on hospital personnel who implement transplan-
tation procedures, great effort is being made to overcome the
donor shortage problem.Marginal donor evaluation using ex vivo lung perfusion
ﬁndings [3] is another emerging technique. Several Japanese
institutions are preparing to unveil this system, and one team
has recently started including ex vivo ﬁndings in donor
evaluation. The feasibility of using this technique for lung
donated after cardiac death has been studied by a working
group, though the hurdle remains high.
Fundamentally, brain-dead-donor lung transplantation is
preferable, though living-donor lung transplantation is one
option to pursue in coping with the donor shortage. However,
there are several limitations to overcome, including mismatched
lung capacity between the donor and recipient. For adults,
transplantation of two lobes is generally necessary, while trans-
plantation of a single lobe is often sufﬁcient for children. The
right lower lobe is usually transplanted into the right thorax, but
in small children, the right lower lobe from an adult is too large.
At present, a pulmonary segment such as the right basal
segment is generally transplanted in such cases.
In lung transplantation, the three-dimensional position of
the pulmonary artery and vein after performing bronchial
anastomosis is important, as the lung becomes congested
when the vessels are bent or constricted. Recently, the ﬁrst
transplantation of a right middle lobe was performed in Japan
by solving various problems related to vascular anastomosis
[4]. Furthermore, technical innovations in lobar transplanta-
tion, such as transplanting the basal segment of the divided
right lower lobe into the right thorax and the right S6 into the
left thorax, are proceeding. In adults, living-donor lung trans-
plantation is sometimes abandoned because the total vital
capacity of the left and right lower lobes fail to satisfy the
predicted vital capacity of the recipient according to the
adaptive criteria. In humans, the right lower lobe is typically
the largest, followed by the left upper lobe and left lower lobe.
If two right lower lobes can be used to replace a left lower lobe,
this problem can be largely remedied. As a result of a detailed
study that utilized a right lower lobe model manufactured by a
3-D printer, a procedure for transplanting the right lower lobe
into the left thorax was developed and performed for the ﬁrst
time, and data continues to be accumulated.
We believe that new initiatives in transplantation medi-
cine in Japan along with progressive technical innovations
will continue to help affected individuals.
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